Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $35.67 $43.20 Thursday, 9th May 2024 CLDX stock ended at $41.06. This is 0.364% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.12% from a day low at $41.01 to a day high of $41.88.
90 days $35.03 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
May 31, 2016 $66.00 $68.85 $65.70 $68.70 187 562
May 27, 2016 $62.55 $65.10 $61.35 $64.95 96 460
May 26, 2016 $63.75 $64.50 $62.10 $62.55 119 045
May 25, 2016 $63.45 $65.70 $62.55 $63.30 182 378
May 24, 2016 $64.80 $65.55 $60.90 $63.15 240 812
May 23, 2016 $60.75 $67.50 $60.45 $64.05 283 510
May 20, 2016 $58.50 $60.45 $57.60 $60.45 202 003
May 19, 2016 $58.65 $61.80 $57.75 $58.20 182 075
May 18, 2016 $55.65 $59.10 $55.65 $58.95 135 471
May 17, 2016 $57.30 $59.10 $55.65 $56.10 180 945
May 16, 2016 $55.80 $58.05 $54.75 $57.75 185 647
May 13, 2016 $51.75 $57.30 $51.75 $56.10 181 481
May 12, 2016 $53.85 $54.90 $51.15 $51.90 187 842
May 11, 2016 $57.00 $57.75 $53.10 $53.55 158 265
May 10, 2016 $58.95 $60.00 $55.50 $57.30 147 421
May 09, 2016 $52.35 $59.40 $51.45 $58.80 264 842
May 06, 2016 $52.65 $53.70 $51.00 $52.35 178 129
May 05, 2016 $58.50 $59.40 $52.20 $52.35 314 276
May 04, 2016 $61.20 $63.15 $57.30 $57.45 245 111
May 03, 2016 $61.95 $65.70 $60.45 $61.05 238 502
May 02, 2016 $61.35 $63.15 $59.25 $62.25 193 780
Apr 29, 2016 $63.00 $65.70 $59.55 $60.00 216 991
Apr 28, 2016 $59.40 $66.90 $59.25 $62.85 283 383
Apr 27, 2016 $60.30 $62.85 $57.60 $61.20 213 952
Apr 26, 2016 $60.75 $62.10 $58.65 $59.40 275 904
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT